Trichomegaly and Trichiasis Associated with Pemigatinib
Abstract
A 30-year-old woman with metastatic intrahepatic cholangiocarcinoma was started on pemigatinib, a fibroblast growth factor receptor (FGFR) inhibitor, which was recently approved by the US Food and Drug Administration. Her baseline eye examination before starting pemigatinib was normal. Six weeks later, she developed ocular irritation. Her examiation revealed lengthened wire-like eyelashes (Fig A, right eye; Fig B, left eye) with lash-corneal...
Paper Details
Title
Trichomegaly and Trichiasis Associated with Pemigatinib
Published Date
Sep 1, 2021
Journal
Volume
128
Issue
9
Pages
1364 - 1364
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History